Myeloablative vs non-myeloablative conditioning with allogeneic stem cell transplantation for high risk now Hodgkin's lymphoma: Similar outcomes despite differences in disease risk

被引：0
|
作者：
Hewitt, M [1 ]
Porter, DL [1 ]
Hummel, K [1 ]
McAlee, A [1 ]
Phillips, J [1 ]
Stadtmauer, E [1 ]
Schuster, S [1 ]
Luger, S [1 ]
Nasta, S [1 ]
Tsai, D [1 ]
Loren, A [1 ]
Perl, A [1 ]
Emerson, S [1 ]
Goldstein, SC [1 ]
机构：
[1] Univ Penn, Blood & Marrow Stem Cell Transplant Program, Philadelphia, PA 19104 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.079
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
79
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [21] Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia
    Ram, Ron
    Storb, Rainer
    Sandmaier, Brenda M.
    Maloney, David G.
    Woolfrey, Ann
    Flowers, Mary E. D.
    Maris, Michael B.
    Laport, Ginna G.
    Chauncey, Thomas R.
    Lange, Thoralf
    Langston, Amelia A.
    Storer, Barry
    Georges, George E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (08): : 1113 - 1120
  • [22] Outcomes of allogeneic hematopoietic stem cell transplantation (HCT) after non-myeloablative conditioning in relapsed, refractory, or transformed indolent non-hodgkin lymphoma (NHL).
    Rezvani, Andrew R.
    Sandmaier, Brenda M.
    Storer, Barry
    Maris, Michael
    Agura, Edward
    Maziarz, Richard
    Wade, James C.
    Chauncey, Thomas
    Forman, Stephen J.
    Niederwieser, Dietger W.
    Shizuru, Judith
    Langston, Amelia
    Pulsipher, Michael
    Storb, Rainer F.
    Maloney, David G.
    BLOOD, 2006, 108 (11) : 891A - 891A
  • [23] Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome
    E Juvonen
    L Volin
    A Koponen
    T Ruutu
    Bone Marrow Transplantation, 2002, 29 : 457 - 458
  • [24] Non-myeloablative stem cell transplantation for mantle cell lymphoma
    Van Steenweghen, S
    Maertens, J
    Schots, R
    Van de Velde, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S254 - S254
  • [25] Morbidity and mortality with non-myeloablative compared to myeloablative conditioning before stem cell transplantation
    Brychtova, Y.
    Doubek, M.
    Krejci, M.
    Muzik, J.
    Navratil, M.
    Mayer, J.
    Vorlicek, J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S93 - S94
  • [26] Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation.
    Mackinnon, S
    Kottaridis, P
    Perry, A
    Chakrabarti, S
    Milligan, DW
    Pettengell, R
    Chopra, R
    Morgan, G
    Hale, G
    Waldmann, H
    Linch, DC
    Devereux, S
    Goldstone, AH
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 31 - 31
  • [27] Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome
    Juvonen, E
    Volin, L
    Koponen, A
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 2002, 29 (05) : 457 - 458
  • [28] Pseudothrombocytopenia after allogeneic non-myeloablative stem cell transplantation
    Gillis, S
    Eisenberg, ME
    Shapira, MY
    Or, R
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (09): : 671 - 673
  • [29] Infections after allogeneic haematopoietic stem cell transplantation with a non-myeloablative conditioning regimen
    Frere, P
    Baron, F
    Bonnet, C
    Hafraoui, K
    Pereira, M
    Willems, E
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2005, 35 : S164 - S164
  • [30] Allogeneic peripheral blood stem cell transplantation using a non-myeloablative conditioning regimen for malignant lymphoma.
    Nagler, A
    Or, R
    Naparstek, E
    Varadi, G
    Slavin, S
    BONE MARROW TRANSPLANTATION, 1999, 23 : S23 - S23
12345